Insider Stock Trading History of Marguglio David J.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Marguglio David J. since year 2005. The trader's CIK number is 1461753. At the time of this reporting, Marguglio David J. is the SR. VP of Corporate Devel. of Cellegy Pharmaceuticals Inc . (stock ticker symbol CLGY). See this page for all insider trading activities at Cellegy Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Marguglio David J. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-06-02 ADMP Cellegy Pharmaceuticals Inc Sale 700 9.00 6,301
2016-05-16 ADMP Cellegy Pharmaceuticals Inc Sale 4,000 8.08 32,340
2016-05-09 ADMP Cellegy Pharmaceuticals Inc Sale 4,860 10.00 48,600
2016-05-03 ADMP Cellegy Pharmaceuticals Inc Sale 1,140 9.00 10,260
2016-04-14 ADMP Cellegy Pharmaceuticals Inc Sale 12,000 7.52 90,216
2015-04-20 ADMP Cellegy Pharmaceuticals Inc Sale 200 5.00 1,000
2015-04-17 ADMP Cellegy Pharmaceuticals Inc Sale 100 5.01 501
2015-04-16 ADMP Cellegy Pharmaceuticals Inc Sale 700 5.00 3,500
2015-04-13 ADMP Cellegy Pharmaceuticals Inc Sale 2,100 5.01 10,525
2015-04-14 ADMP Cellegy Pharmaceuticals Inc Sale 100 5.00 500
2015-03-04 ADMP Cellegy Pharmaceuticals Inc Sale 11,800 7.09 83,662
2015-03-02 ADMP Cellegy Pharmaceuticals Inc Sale 7,000 6.45 45,150
2015-01-08 ADMP Cellegy Pharmaceuticals Inc Sale 200 7.00 1,400
2015-01-05 ADMP Cellegy Pharmaceuticals Inc Sale 7,000 6.18 43,260
2014-12-29 ADMP Cellegy Pharmaceuticals Inc Sale 772 6.00 4,632
2014-12-30 ADMP Cellegy Pharmaceuticals Inc Sale 12,228 6.09 74,468
2014-12-12 ADMP Cellegy Pharmaceuticals Inc Sale 4,000 5.18 20,740
2014-09-02 ADMP Cellegy Pharmaceuticals Inc Sale 8,000 5.06 40,472
2014-06-02 ADMP Cellegy Pharmaceuticals Inc Sale 4,000 5.56 22,256

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Marguglio David J. (SR. VP of Corporate Devel. of Cellegy Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.